PELLETIER SAUNDRA L 4
4 · Evofem Biosciences, Inc. · Filed Mar 9, 2021
Insider Transaction Report
Form 4
PELLETIER SAUNDRA L
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2021-03-09$2.28/sh+45,249$103,168→ 906,137 total
Footnotes (2)
- [F1]These purchases were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.21 to $2.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.